Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Understanding sex and gender differences can improve personalized dermatology care.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Potential therapeutic targets for scarring hair loss are identified.

Low BMI and cold exposure increase the risk of chilblains.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Early diagnosis and lifelong zinc supplementation are crucial for treating acrodermatitis enteropathica effectively.

New treatments for seborrheic dermatitis show promise for difficult cases.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

A man wrongly believed he had parasites, showing that delusional infestation can affect men and is often linked with other psychiatric issues, but can be treated with antipsychotics.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

The document concludes that the acoustic coupler SF-001 is good for skin ultrasound, especially on rough body parts, because it's stable and shows blood vessels well.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Teucrium polium extracts are non-toxic and effectively speed up wound healing.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.